ARCHIVES

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

This article is from The Cancer Letter archive.

Vol. 32 No. 03 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992